Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FZD5 |
| Upstream (Parents) |
|---|
| (<<) ALK → FZD5 |
| (<<) ARSA → FZD5 |
| (<<) CAT → FZD5 |
| (<<) CHSY1 → FZD5 |
| (<<) EDNRA → FZD5 |
| (<<) GALK1 → FZD5 |
| (<<) GPNMB → FZD5 |
| (<<) GRB2 → FZD5 |
| (<<) HIF1A → FZD5 |
| (<<) HS3ST2 → FZD5 |
| (<<) IL1RN → FZD5 |
| (<<) LRP5 → FZD5 |
| (<<) LTA4H → FZD5 |
| (<<) MAL → FZD5 |
| (<<) PIP4K2A → FZD5 |
| (<<) RHOQ → FZD5 |
| (<<) SPR → FZD5 |
| (<<) TGFA → FZD5 |
| (<<) TUBA1A → FZD5 |
| (<<) VIM → FZD5 |
| Downstream (Children) |
|---|
| FZD5 → CSF2 (>>) |
| FZD5 → CXCR7 (>>) |
| FZD5 → FLJ22184 (>>) |
| FZD5 → FZD2 (>>) |
| FZD5 → INVS (>>) |
| FZD5 → MMP17 (>>) |
| FZD5 → RRAS2 (>>) |
| FZD5 → SOX18 (>>) |
